Showing 1,621 - 1,640 results of 104,191 for search '(( 50 we decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 1621
  2. 1622
  3. 1623
  4. 1624
  5. 1625
  6. 1626
  7. 1627
  8. 1628
  9. 1629

    IL-8 secretion decreased from TLR5 silenced (siRNA) Caco-2BBe cells exposed to flagellin. by Tonyia Eaves-Pyles (344135)

    Published 2013
    “…<p><b>A. </b><i>S. dublin</i> flagellin was added to the AP or BL surface of polarized Caco-2BBe cells where TLR5 was knocked down using siRNA. …”
  10. 1630
  11. 1631
  12. 1632
  13. 1633
  14. 1634

    Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development by Hafsa Amat-ur-Rasool (702613)

    Published 2015
    “…There is no effective vaccine available, so far, against any of its four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). There is a need for the development of preventive and therapeutic vaccines against DENV to decrease the prevalence of dengue fever, especially in Pakistan. …”
  15. 1635

    CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner by Jun Chen (4238)

    Published 2023
    “…CircAGFG1 and PKM2 expression were significantly increased, while miR-7-5p was decreased in L-OHP-resistant CRC tissues and cells. …”
  16. 1636
  17. 1637
  18. 1638
  19. 1639

    MiR-10a-5p expression was reduced and miR-10a-5p overexpression was correlated with longer OS in melanoma. by Haijun Zhu (533051)

    Published 2021
    “…<b>(D)</b> The comparison for miR-10a-5p expression was performed between early-stage melanoma and advanced stage melanoma in TCGA database. …”
  20. 1640

    Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled T... by Chunfeng Qu (114656)

    Published 2014
    “…The participation rates of the two surveys were 57.5% (21,770) and 50.7% (17,204) in the vaccination group and 36.3% (12,184) and 58.6% (17,395) in the control group, respectively. …”